AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 8 filers reported holding AYALA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $240,000 | -64.7% | 60,220 | -24.7% | 0.08% | -61.5% |
| Q4 2021 | $680,000 | -81.2% | 79,964 | -74.9% | 0.20% | -82.2% |
| Q3 2021 | $3,613,000 | -34.7% | 318,599 | -41.3% | 1.15% | -16.2% |
| Q2 2021 | $5,533,000 | +3.5% | 542,977 | +10.8% | 1.38% | +26.7% |
| Q1 2021 | $5,346,000 | +210.3% | 489,988 | +212.8% | 1.08% | +207.4% |
| Q4 2020 | $1,723,000 | -6.5% | 156,655 | -2.1% | 0.35% | -3.3% |
| Q3 2020 | $1,843,000 | +59.3% | 159,966 | +39.7% | 0.36% | +8.0% |
| Q2 2020 | $1,157,000 | – | 114,546 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 542,977 | $5,533,000 | 1.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,364 | $238,000 | 0.11% |
| Redmile Group, LLC | 667,816 | $6,805,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31,962 | $326,000 | 0.01% |
| Marshall Wace North America L.P. | 49,266 | $502,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 704,363 | $7,178,000 | 0.00% |
| Chevy Chase Trust Holdings, LLC | 15,000 | $153,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 470 | $4,000 | 0.00% |
| UBS Group AG | 5,509 | $56,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |